Target intelligence / Profile preview

Pathogen-associated molecular patterns and damage-associated molecular patterns (PAMPs/DAMPs)

Target
PAMPs/DAMPs
Molecular classification
Other, Ligand, Antigen, Molecular pattern
01

Overview

Pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) are diverse classes of molecules that serve as the primary triggers for the innate immune system (Janeway & Medzhitov, 2002). PAMPs are exogenous, highly conserved molecular structures produced by microorganisms—such as lipopolysaccharides (LPS), flagellin, and viral RNA—that are recognized by pattern recognition receptors (PRRs) like Toll-like receptors (TLRs) (Kono & Rock, 2008). DAMPs, or alarmins, are endogenous molecules released from damaged, stressed, or necrotic host cells, including HMGB1, ATP, and heat shock proteins, which signal 'sterile' tissue damage (Matzinger, 1994). While these molecules are not individual therapeutic targets in the classical sense, they are central to the pathogenesis of sepsis, autoimmune disorders, and cancer (Roh & Sohn, 2018). Therapeutic interventions often utilize synthetic PAMPs as vaccine adjuvants to enhance immunogenicity or employ neutralizing agents against specific DAMPs to mitigate excessive inflammation in chronic diseases (Venereau et al., 2015).

Other names
Pattern-associated molecular patternsDamage-associated molecular patternsMicrobial-associated molecular patternsMAMPsAlarminsDanger-associated molecular patternsMicrobial antigens
02

Mechanism of action

Agonism of pattern recognition receptors (PRRs) to stimulate innate and adaptive immunity, or neutralization of specific patterns to inhibit pathological inflammation.

03

Biological functions

Immune responseInflammationSignal transductionApoptosisCell deathWound healing
04

Disease associations

InfectionInflammationSepsisAutoimmune diseaseCancerCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Cytokine release syndromeSystemic inflammatory response syndrome (SIRS)AutoimmunityOff-target immune activationChronic inflammation
06

Interacting drugs

Monophosphoryl lipid A

7 more in the full profile.

07

Biomarkers

High mobility group box 1 (HMGB1)S100 proteinsC-reactive protein (CRP)ProcalcitoninCell-free DNAMitochondrial DNAInterleukin-6 (IL-6)

Beyond the preview

Go deeper on Pathogen-associated molecular patterns and damage-associated molecular patterns (PAMPs/DAMPs).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen-associated molecular patterns and damage-associated molecular patterns (PAMPs/DAMPs).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call